This week ImmunXperts will be in South Korea at the 2nd Annual PEGS Summit Korea held from 20-22 Sept in Seoul. Sofie Pattijn will be talking on the use of in vitro assays in the development of cancer immunotherapies.
With the new wave of candidate cancer therapies acting mainly on the immune system via immune checkpoint blockade and other pathways, the demand for in vitro characterization of these molecules has significantly increased. The presentation will give a technical overview of a series of in vitro assays using human primary cells used for the characterization of new leads. Also, the major benefits, limitations and challenges will be discussed.